Malecare Advanced Prostate Cancer Teleconference
Join us for a conversation about treating advanced stage prostate cancer, with James M. McKiernan, M.D. and Joel Nowak, M.A., M.S.W. […]
Baseline PSA Predicts Risk of Death from Prostate Cancer
The common question when we are diagnosed with prostate cancer is how long do I have to live? The exact same question is asked again when we discover that we have had a prostate cancer recurrence. Times have changed and so has our potential life span. In the late 1980s and early 1990s men diagnosed [...]
The Long-Term Survival of Patients with Metastatic Prostate Cancer
Mike Scott who writes the THE “NEW” PROSTATE CANCER INFOLINK today published an excellent summary/discussion about survival time for men with metastatic prostate cancer. He presents a synopsis about anticipated survival going back to the late 1980s and brings the conversation up to our current condition. He reminds us that our next big step will [...]
Prostate Cancer Deaths Predicted to Rise By 17 Percent in 2010 !
Did you hear the news? These alarming 2010 projections for prostate cancer deaths were just released. Isn't it nice that they were released just prior to Father’s Day, so have a happy Father’s Day. These projections call for a massive 17 % increase in prostate cancer caused deaths as well as a more than 13 [...]
On The Horizon – A Status Report of Six New Promising Advancing Treatments for Men with Advanced Prostate Cancer as of the Beginning of June, 2010
As of today there are many different potential drugs undergoing phase III evaluations for men with advanced prostate cancer, some of them seem to offer great hope and promise. Considering we just had Provenge finally approved, this is great news. […]
Provenge, It Isn’t Over Priced, Its Actually A Bargain Basement Product
There remain for many people questions about Provenge. The most common question I hear is about the financial cost of the treatment for what has been described as “only 4 months of life extension for $93,000, is it worth it?” Well, the answer is a clear yes! […]
FDA Probes Breast Cancer Risk of Avodart & Proscar
The Food and Drug Administration (FDA) has announced that it is looking into reports that Glaxo Smith Kline’s prostate drug Avodart and Merck & Co’s prostate drug Proscar may be contributing to an increase of male breast cancers. […]
Analyzing Prostate Cancer Using the CTC-Chip – Insights into the Prognosis of Recurrent Prostate Cancer
Using a CTC-chip that measures the level of circulating tumor cells in blood can provide an important insight into the prognosis and potential rates of recurrent disease, according to data from a developing study at Massachusetts General Hospital, which was presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010. [...]
Advanced Prostate Cancer “Wiki” on Facebook
Join and participate in my new facebook "wiki" page called ADVANCED PROSTATE CANCER.
Malpractice and Withholding PSA Tests
I have been reading in the press about a recent medical malpractice settlement surrounding prostate cancer. Briefly, a man went to his primary care physician who, along with other tests, performed a DRE and PSA test. The doctor failed to inform his patient about the negative test results which were indicative of a diagnosis of [...]